S&P Stock Picks and Pans: Celgene, Autodesk, AstraZeneca

Analysts' opinions on stocks in the news

S&P REITERATES BUY OPINION ON SHARES OF CELGENE (CELG; 48.44):

To continue reading this article you must be a Bloomberg Professional Service Subscriber.